N-(4-sec-butylphenyl)-2-[(4-fluorobenzyl)amino]nicotinamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-sec-butylphenyl)-2-[(4-fluorobenzyl)amino]nicotinamide
• 英文别名: N-(4-butan-2-ylphenyl)-2-[(4-fluorophenyl)methylamino]pyridine-3-carboxamide
• 化学式: C₂₃H₂₄FN₃O
• 分子量: 377.461
• InChiKey: FZAHZRJHOKBWIY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  54
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Substituted arylamine derivatives and methods of use
  申请人：——

  公开号：US20020147198A1

  公开（公告）日：2002-10-10

  Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对预防和治疗疾病，如介导血管生成的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药用可接受的衍生物，用于预防和治疗涉及癌症等疾病和其他疾病或情况的药物组合物和方法。该发明还涉及用于制备这种化合物的工艺，以及在这些工艺中有用的中间体。
• N-PYRIDYL CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：Amgen Inc.

  公开号：EP1358161A2

  公开（公告）日：2003-11-05
• SUBSTITUTED BENZYLAMINE DERIVATIVES AND METHODS OF USE
  申请人：AMGEN INC.

  公开号：EP1583744A2

  公开（公告）日：2005-10-12
• US7101868B2
  申请人：——

  公开号：US7101868B2

  公开（公告）日：2006-09-05
• [EN] SUBSTITUTED ARYLAMINE DERIVATIVES AND METHODS OF USE<br/>[FR] DERIVES D'ARYLAMINE SUBSTITUES ET LEURS METHODES D'UTILISATION
  申请人：AMGEN INC

  公开号：WO2002055501A2

  公开（公告）日：2002-07-18

  Selected compounds of formula (I), wherein each of A?1 and A2¿ is independently C or N; wherein A1-A2 form part of a ring A selected from 5- or 6- membered heteroaryl; wherein X is; wherein Z is oxygen or sulfur; are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.